Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GATE: AL-8309B in Geographic Atrophy
NCT00890097Phase 3Terminated
- Sponsor
- Alcon Inc.
- Start
- Apr 2009
- Primary completion
- May 2012
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of tandospirone in geographic atrophy (GA), sponsored by Alcon Inc.. Started Apr 2009; status: terminated.
02
Drugs
tandospirone
03
Conditions
geographic atrophy (GA)
Beyond the preview
Go deeper on NCT00890097.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00890097.